OncoSec Medical Receives New Coverage from Analysts at Maxim Group (ONCS)
Equities research analysts at Maxim Group started coverage on shares of OncoSec Medical (NASDAQ:ONCS) in a research note issued to investors on Tuesday, Stock Ratings Network reports. The firm set a “buy” rating and a $3.00 price target on the stock.
Shares of OncoSec Medical (NASDAQ:ONCS) opened at 0.2539 on Tuesday. OncoSec Medical has a 1-year low of $0.18 and a 1-year high of $0.49. The stock has a 50-day moving average of $0.2 and a 200-day moving average of $0.27. The company’s market cap is $43.4 million.
Separately, analysts at Roth Capital initiated coverage on shares of OncoSec Medical in a research note to investors on Tuesday, August 6th. They set a “buy” rating on the stock.
OncoSec Medical Incorporated is an emerging drug-medical device company. The Company focused on designing, developing and commercializing medical approaches for the treatment of solid cancers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.